Medtronic is innovating for today’s healthcare professionals.

Leading-Edge Technology

Medtronic is committed to improving clinical outcomes with the latest diabetes care technology:

• Developed the first insulin pump integrated with continuous glucose monitoring (CGM)

• Launched the world’s first professional CGM device

• Paved the way to breakthroughs in care, such as low glucose suspend

Unrivaled Service and Support

We recognize the value of your time and the importance of creating a more efficient practice. That’s why we provide convenient services to meet the needs of your busy schedule.

• Contact us on your terms: Our live help is available 24 hours a day, 7 days a week, 365 days a year—saving you time and offering your patients unsurpassed flexibility

• Education that is easy to implement and engage: MedtronicDiabetes.com provides patients convenient access to a versatile curriculum of easy-to-navigate educational programs—because improving knowledge can lead to better outcomes

• Personal assistance is always available: Medtronic has over 700 field representatives available to provide you with constant support

Uncompromising Leadership

We are completely dedicated to medical research. Currently, Medtronic invests more than 10% of its annual revenue in R&D to accelerate clinical advancements.

Engaging you and your patients more effectively is key to creating a greater understanding of diabetes care. Our recent expansion of our second Diabetes Therapy Management and Education Center (located in San Antonio, Texas) is a result of the progress we continue to make.

We invest significantly in clinical studies, including the landmark STAR 3 trial.

• STAR 3 demonstrated that nearly three times as many adult patients—and twice as many pediatric patients—achieved recommended A1C on insulin pump therapy vs. patients using MDI1

• CGM can improve detection of hypoglycemic events2,3

Medtronic invests over $400 million per year in service and support to help you help your patients. Here are 3 ways we make it easier for you to succeed in your practice:

1. Making it Easier to Learn

   • Over 2,800 Certified Product Trainers provide on-boarding guidance

   • CME programs for professional education showcase the latest in diabetes care and Medtronic developments

   • MedtronicDiabetes.com provides patients an event finder tool to help locate local groups for live product training and diabetes education

   • myLearning provides patient education on the basics of insulin pump therapy, and software use. You may view what your patients are learning in myLearningView

2. Making it Easier to Process

   • Insurance assistance is offered by Medtronic customer service representatives to help patients with claim submissions and answer questions

3. Making it Easier to Afford

   • Financial assistance for patients who qualify

IMPORTANT SAFETY INFORMATION >

1

Bergenstal RM, Tamborlane WV, Ahmann A, et al; the STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-320.

2

Keenan DB, Cartaya R, Mastrototaro JJ. Accuracy of a new real-time continuous glucose monitoring algorithm. J Diabetes Sci Technol. 2010;4(1):111-118.

3

Mastrototaro J, Shin J, Marcus A, Sulur G; STAR 1 Clinical Trial Investigators. The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. Diabetes Technol Ther. 2008;10(5):385-390.